{"id":"prospective-tdm-arm","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The 'Prospective TDM Arm' refers to a clinical trial cohort at Johns Hopkins University that uses therapeutic drug monitoring to guide individualized drug dosing in real-time, rather than using fixed standard doses. This approach aims to maintain drug concentrations within optimal therapeutic windows, potentially improving efficacy and reducing toxicity compared to standard dosing.","oneSentence":"This is a prospective therapeutic drug monitoring (TDM) study arm, not a drug itself, designed to optimize dosing through real-time concentration monitoring.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:03:14.126Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01845246","phase":"NA","title":"Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2012-01","conditions":"Multidrug Resistant Gram Negative Bacterial Infections","enrollment":101},{"nctId":"NCT01416025","phase":"PHASE4","title":"A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-01","conditions":"Fungal Infection","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["VFEND"],"phase":"marketed","status":"active","brandName":"Prospective TDM Arm","genericName":"Prospective TDM Arm","companyName":"Johns Hopkins University","companyId":"johns-hopkins-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}